Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Grace Therapeutics, Inc GRCE

Healthcare
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

Bullboard (NDAQ:GRCE)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Comment by lscfaon Aug 13, 2020 10:10am

RE:Why Today?

Nasdaq deadline to report Q2.......
165
Discussion
Post by Danny1082Manon Aug 13, 2020 10:00am

Why Today?

They could have easily pushed out earnings PR into September. What is the motivation to tell they market they diluted with another 4 million shares with the ATM. Along with increased salaries verses ...more  
287
Discussion
Post by nandolino123on Aug 13, 2020 8:48am

News out

Looks like we finally have an explanation on the unusual placebo affect... 
168
Comment by Danny1082Manon Aug 12, 2020 8:27pm

RE:RE:RE:RE:T2

Correct. Florida sites in T1 made up 35% (24 of 69) while in T2 Florida made up 15% (10 of 68) sites. Canada and Mexico are 23% of sites in T2. Hope to see more 1:1 patient/doctor experience and not ...more  
198
Discussion
Comment by Rosmorducon Aug 12, 2020 7:14pm

RE:RE:RE:T2

I suggest you call Investor Relations.  They will provide you the same details I gave you earlier. T2 is a much vaster study with more labs and more countries involved. If the same mess-up ...more  
172
Discussion
Comment by 3burtcon Aug 12, 2020 4:55pm

RE:RE:T2

I have to disagree with you. If T2 has the same issues then i have to believe clinical trials will need to be redone. We are looking for a near perfect news release, if we get it, sky's the limit!
137
Discussion
Comment by Rosmorducon Aug 12, 2020 12:18pm

RE:T2

There are much more additional sites (and countries) for T2 versus T1. The 5 problematic sites where the patients did not fast properly and saw a reduction in TG with cornstarch will have much less ...more  
185
Discussion
Post by 3burtcon Aug 11, 2020 7:26pm

T2

Hi! I have a small position of 5000 shares and was wondering what the chances of T2 having the same issues as T1? Was T2 under way before they realized the issues of T1?
264
Discussion
Comment by Rosmorducon Aug 10, 2020 2:29pm

RE:RE:RE:RE:RE:RE:RE:T2 Data Release

Thanks Francine. I think nobody can dispute that Jan has been a horrible CEO. Why she was chosen in the first place is beyond my understanding - she has no knowledge, no connections, no strategy, no ...more  
188
Discussion
Comment by Francine01on Aug 10, 2020 12:13pm

RE:RE:RE:RE:RE:RE:T2 Data Release

Ros, be my guest for the question. I often was critical about the mannagement, they don't answer by questions ..  they won't anwser you or they will say that Jan drop a short sentence in ...more  
180
Discussion
Comment by Rosmorducon Aug 10, 2020 11:31am

RE:RE:RE:RE:RE:T2 Data Release

Perhaps that deal is still in effect but awaiting P3? I mean you can't just put out a press release like that and have nothing.  I think we should all contact the company and ask for some ...more  
162
Discussion
Comment by Francine01on Aug 10, 2020 11:11am

RE:RE:RE:RE:T2 Data Release

I wrote several posts on the "Chinese deal" PR in November 2017. For me, there is no doubt in my mind that Jan should be send to jail for this story.   They PR a $125M "non ...more  
185
Discussion
Comment by Danny1082Manon Aug 10, 2020 11:06am

RE:RE:RE:T2 Data Release

Looks like shareholders meeting is September 30th. So Jan's job now rests on T2 data
113
Discussion
Comment by willyk3on Aug 10, 2020 10:20am

RE:RE:RE:T2 Data Release

You are absolutely right Francine and to your list u can add that ridiculous news release that she w was responsible for. U remember the one ....a few years back ... Announcing their Asian connection  ...more  
142
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities